.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
The Botanist is stocked at 506 licensed dispensaries across New York, Illinois, and 4 other states, 154 of them in New York, with the deepest coverage in New York, Brooklyn, Queens, Staten Island, and Albany. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
The Botanist’s August 2026 mix is anchored by Flower at 68.8% share with 148.7% year-over-year growth and 54.6% month-over-month acceleration, while Pre-Roll holds 12.3% share with 166.4% YoY and 17.0% MoM growth. Vapor Pens account for 16.9% share but declined 12.7% YoY despite an 11.1% MoM uptick, and Edible contracted to 1.5% share with -38.5% YoY and -12.4% MoM. Tincture & Sublingual sits at 0.5% share with -41.9% YoY and -21.7% MoM, and Concentrates fell to 0.05% share with -27.2% YoY and -72.9% MoM. With average price up 6.7% YoY and Flower’s average price at $42.34, the mix implies deliberate volume and price-driven focus on inhalables, reinforced by a Flower rank of 4 in Illinois.
The shift toward Flower and Pre-Roll, combining 81.0% share with triple-digit YoY growth in both (148.7% and 166.4%), positions The Botanist squarely in daily-use, high-frequency occasions where price elasticity can support a 6.7% higher brand-wide average price without suppressing volume. The concurrent 12.7% YoY contraction in Vapor Pens against an 11.1% MoM rebound suggests replenishment-led volatility rather than structural decline, while Edible at -38.5% YoY and Tincture & Sublingual at -41.9% YoY indicate deprioritization of ingestibles. Concentrates’ -72.9% MoM drop, despite a $55.58 average price, points to a tactical exit from low-share niches, implying a focused strategy to defend and climb from rank 4 in Illinois Flower by consolidating around fast-turn inhalables.
Competitive Landscape
In Illinois Flower for August 2026, The Botanist sits at rank 4 after a year-over-year jump of 25 positions from rank 29, and it also climbed 15 spots from rank 19 three months ago to reach a new peak rank of 4 in August 2026; by contrast, High Supply / Supply held rank 1 year-over-year and remains rank 1 now despite a 10.1% sales decline, while RYTHM stayed at rank 2 with a 37.0% sales increase and Good Green held rank 3 alongside a 5.2% sales decline. The Botanist’s acceleration into the top 5 alongside a flat rank landscape for rank 1–3 implies share is consolidating at the top and that further gains will likely require trading against incumbents with divergent momentum (expansion against RYTHM’s growth or displacement during High Supply / Supply and Good Green’s contraction), even if near-term dollar volumes remain concentrated among ranks 1–3.
Notable Products
Mint Sherbert (3.5g) posted the steepest decline at -22% MoM in August 2026 while slipping behind Grapple Pie (3.5g) and Billionaire (3.5g) at ranks 1 and 2, respectively, which reorders the top three around resilience versus volatility and indicates exposure to flavor-cycle risk. Billionaire (3.5g) delivered the largest MoM gain at +55% and climbed to rank 2, narrowing the gap with rank-1 Grapple Pie (+40% MoM), while LA Kush Cake (3.5g) edged up +7% at rank 5, and six of the top ten are Flower SKUs, signaling a portfolio still concentrated in classic eighths. Bold - Blue Razzberry Distillate Cartridge (1g) dipped -3% at rank 9 as Pre-Roll entries like Billionaire Pre-Roll variants landed at ranks 4 and 8 with $95,515 in the multi-pack, implying The Botanist is testing trade-up formats while vapor traction lags Flower momentum. Overall, the mix points to a Flower-led strategy anchored by a breakout in the Billionaire line, with selective expansion into Pre-Rolls to capture basket-building without overextending into Vapor Pens.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
